Clinical operations field note
Sponsor and CRO Roles in Clinical Trial Oversight
Compare sponsor and CRO perspectives on clinical trial oversight and clarify escalation, decision authority, and accountability.
By Lampgen Clinical Research
1 min read · estimated
- THE CRO LENS Visit delivery • report timelines • site actions • monitoring metrics • contractual scope
- THE SPONSOR LENS Program impact • vendor performance • cross-study risk • regulatory exposure • portfolio priorities
- STRONG OVERSIGHT CONNECTS BOTH VIEWS. Site observations must become study-level context and action.
Sponsor oversight is not a second version of CRO project management.
The CRO may be focused on visit delivery, monitoring reports, site action items, timelines, and contractual scope.
The sponsor must also understand what those activities mean across the study and program: recurring site patterns, vendor performance, enrollment risk, data quality, regulatory exposure, and competing portfolio priorities.
The handoff matters.
A site issue should not stop at “closed.” The sponsor needs enough context to determine whether the same pattern exists elsewhere and whether a broader action is required.
Lampgen’s experience across sponsor and CRO environments informs how we evaluate clinical-operations talent and oversight needs.